Replicel Life Sciences Stock Today

RP Stock  CAD 0.06  0.00  0.00%   


0 of 100

Very Weak

Odds Of Distress

Over 86

Very High
RepliCel Life is selling for under 0.055 as of the 16th of July 2024; that is No Change since the beginning of the trading day. The stock's lowest day price was 0.055. RepliCel Life has a very high chance of experiencing financial distress in the next few years of operation. It has also generated negative returns for investors over the last 90 days. Equity ratings for RepliCel Life Sciences are calculated daily based on our scoring framework. The performance scores are derived for the period starting the 16th of June 2024 and ending today, the 16th of July 2024. Click here to learn more.
Business Domain
Pharmaceuticals, Biotechnology & Life Sciences
Health Care
RepliCel Life Sciences Inc., a regenerative medicine company, focuses on developing autologous cell therapies that treat functional cellular deficits. RepliCel Life Sciences Inc. is headquartered in Vancouver, Canada. REPLICEL LIFE operates under Biotechnology classification in Canada and is traded on TSX Venture Exchange.. The company has 65 M outstanding shares of which 869 shares are at this time shorted by private and institutional investors with about 0.13 trading days to cover. More on RepliCel Life Sciences

RepliCel Stock Highlights

Most reasonable investors view market volatility as an opportunity to invest at a favorable price or to sell short against a bearish trend. RepliCel Life's investment highlights are automatically generated signals that are significant enough to either complement your investing judgment regarding RepliCel Life or challenge it. These highlights can help you better understand the position you are entering and avoid costly mistakes.
CEO PresidentAndrew Schutte
Business ConcentrationBiotechnology, Pharmaceuticals, Biotechnology & Life Sciences, Health Care, Health Care, Biotechnology, Biotechnology, Healthcare (View all Sectors)
RepliCel Life's financial strength is of vital concern to both outside investors and internal stakeholders. Efficiency and cost control are keys to RepliCel Life's success, along with its ability to generate sufficient cash flow to pay bills, repay debt, and make a consistent year-to-year profit.
Debt Levels
RepliCel Life can leverage the use of borrowed funds to amplify returns from an investment. In general, analyzing the relationship between debt to total assets helps investors to understand RepliCel Life's financial leverage. It provides some insight into what part of RepliCel Life's total assets is financed by creditors.
RepliCel Life cash flow analysis is essential to understand how it generates and spends money over a specific period. It can also help you figure out where your money is going and how much cash you have available at a given moment. RepliCel Life Sciences currently holds 40.96 K in liabilities. RepliCel Life Sciences has a current ratio of 2.05, suggesting that it is liquid enough and is able to pay its financial obligations when due. Debt can assist RepliCel Life until it has trouble settling it off, either with new capital or with free cash flow. So, RepliCel Life's shareholders could walk away with nothing if the company can't fulfill its legal obligations to repay debt. However, a more frequent occurrence is when companies like RepliCel Life Sciences sell additional shares at bargain prices, diluting existing shareholders. Debt, in this case, can be an excellent and much better tool for RepliCel to invest in growth at high rates of return. When we think about RepliCel Life's use of debt, we should always consider it together with cash and equity.

Total Cash From Financing Activities

1.81 Million
RepliCel Life Sciences (RP) is traded on TSX Venture Exchange in Canada and employs 8 people. RepliCel Life is listed under Biotechnology category by Fama And French industry classification. The company currently falls under 'Nano-Cap' category with a current market capitalization of 3.58 M. Market capitalization usually refers to the total value of a company's stock within the entire market. To calculate RepliCel Life's market, we take the total number of its shares issued and multiply it by RepliCel Life's current market price. To manage market risk and economic uncertainty, many investors today build portfolios that are diversified across equities with different market capitalizations. However, as a general rule, conservative investors tend to hold large-cap stocks, and those looking for more risk prefer small-cap and mid-cap equities. RepliCel Life Sciences conducts business under Biotechnology sector and is part of Health Care industry. The entity has 65 M outstanding shares of which 869 shares are at this time shorted by private and institutional investors with about 0.13 trading days to cover. RepliCel Life Sciences currently holds about 1.16 M in cash with (1.99 M) of positive cash flow from operations. This results in cash-per-share (CPS) ratio of 0.04.
Check RepliCel Life Probability Of Bankruptcy
Ownership Allocation
RepliCel Life owns a total of 65 Million outstanding shares. RepliCel Life holds majority of its outstanding shares owned by insiders. An insider is usually defined as a corporate executive, director, member of the board or institutional investor who own at least 10% of the company's outstanding shares. 62.69 pct. of RepliCel Life Sciences outstanding shares that are owned by insiders implies they have been buying or selling the stock in recent months in anticipation of some upcoming event. Please note that no matter how many assets the company maintains, if the real value of the company is less than the current market value, you may not be able to make money on it.
Check RepliCel Ownership Details

RepliCel Stock Against Markets

Be your own money manager

Our tools can tell you how much better you can do entering a position in RepliCel Life without increasing your portfolio risk or giving up the expected return. As an individual investor, you need to find a reliable way to track all your investment portfolios. However, your requirements will often be based on how much of the process you decide to do yourself. In addition to allowing all investors analytical transparency into all their portfolios, our tools can evaluate risk-adjusted returns of your individual positions relative to your overall portfolio.

Did you try this?

Run Crypto Correlations Now


Crypto Correlations

Use cryptocurrency correlation module to diversify your cryptocurrency portfolio across multiple coins
All  Next Launch Module

RepliCel Life Corporate Management

Elected by the shareholders, the RepliCel Life's board of directors comprises two types of representatives: RepliCel Life inside directors who are chosen from within the company, and outside directors, selected externally and held independent of RepliCel. The board's role is to monitor RepliCel Life's management team and ensure that shareholders' interests are well served. RepliCel Life's inside directors are responsible for reviewing and approving budgets prepared by upper management to implement core corporate initiatives and projects. On the other hand, RepliCel Life's outside directors are responsible for providing unbiased perspectives on the board's policies.
BA CPAChief OfficerProfile
Kevin McElweeChief Scientific OfficerProfile
MSc PMPClinical ConsultantProfile
Ben AustringCorporate OfficerProfile
David CPAChief OfficerProfile
BEd LLBCorp DirectorProfile

Additional Tools for RepliCel Stock Analysis

When running RepliCel Life's price analysis, check to measure RepliCel Life's market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy RepliCel Life is operating at the current time. Most of RepliCel Life's value examination focuses on studying past and present price action to predict the probability of RepliCel Life's future price movements. You can analyze the entity against its peers and the financial market as a whole to determine factors that move RepliCel Life's price. Additionally, you may evaluate how the addition of RepliCel Life to your portfolios can decrease your overall portfolio volatility.